SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-068332
Filing Date
2019-11-27
Accepted
2019-11-27 17:12:26
Documents
4
Period of Report
2019-11-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-20376_68k.htm 8-K 32887
2 EX-5.1 a19-20376_6ex5d1.htm EX-5.1 11494
3 EX-10.1 a19-20376_6ex10d1.htm EX-10.1 262236
4 GRAPHIC g203766kii001.gif GRAPHIC 2189
  Complete submission text file 0001104659-19-068332.txt   311097
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 191258920
SIC: 2834 Pharmaceutical Preparations